Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Medical Genetics

Confirming the Diagnosis: Genetics and Reports

At a Glance

FRTS4 is usually confirmed by finding a disease-causing HNF4A variant, most often p.Arg85Trp (R85W), alongside characteristic kidney and pancreatic features. A genetic report should show the gene, variant, zygosity, and classification; a VUS alone is not diagnostic.

Genetic testing is more than just a label; it is the “GPS coordinate” for your medical care. Because Fanconi Renotubular Syndrome 4 (FRTS4) is so rare, having a confirmed genetic result ensures your care team looks for both the kidney and pancreatic issues discussed on earlier pages.

The Specific “Address”: HNF4A and p.Arg85Trp

The HNF4A gene is large, and different changes within it can lead to different conditions. Most people with the FRTS4 combination carry a very specific “misspelling” at a precise location in the gene known as p.Arg85Trp (also written as R85W) [1].

In the largest study of this condition, 24 out of 25 patients carried this exact variant [1]. This change occurs in the DNA-binding domain, the part of the protein that physically grips other pieces of DNA to turn genes on and off [2]. Other variants like p.Arg63Trp and p.Pro212Leu have also been reported, though they are less common and not every HNF4A variant causes this exact kidney-pancreas phenotype [3][4].

Why This Is Distinctive from Other Fanconi Syndromes

Before genetic testing, many patients are misdiagnosed with other types of Fanconi syndrome. Distinguishing FRTS4 is critical because the combination of HNF4A-related Fanconi syndrome, neonatal hyperinsulinism, and later HNF4A-MODY is distinctive [5]. Other conditions in the differential diagnosis include:

  • Fanconi-Bickel Syndrome: Caused by the SLC2A2 gene. It can cause infantile or fasting hypoglycemia, but this is characterized by glycogen storage and hepatomegaly (enlarged liver), which differs from the hyperinsulinemic hypoglycemia seen in HNF4A [1].
  • Dent Disease: Caused by the CLCN5 or OCRL genes. It is X-linked, meaning it primarily affects males. While it causes similar kidney “leaking,” it generally does not affect the pancreas [6][7].
  • Lowe Syndrome: Also caused by the OCRL gene. It includes the same kidney issues but is distinguished by three major signs not usually seen in FRTS4: congenital cataracts (cloudy eyes at birth), low muscle tone (hypotonia), and intellectual disability [8].

Understanding Inheritance: Autosomal Dominant

FRTS4 is an autosomal dominant condition [9]. This means you only need one copy of the changed gene to have the condition.

  • Transmission Risk: If a parent carries the variant, there is a 50% chance for each child to inherit it.
  • Variable Expression: If a parent does carry the variant, they may have very mild symptoms (like adult-onset diabetes) while their child has the full kidney-pancreas syndrome [4][5].
  • De Novo: Often, the genetic change is “de novo,” meaning it happened for the first time in the patient and was not inherited from a parent [1].

Your Genetic Report Audit

When you receive a genetic test report, it can be a maze of codes. Use this checklist to ensure you have the necessary information to share with specialists.

Item to Locate Why it Matters Example
Gene Name Confirms the correct “master switch” was tested. HNF4A
Protein Change Identifies the exact “misspelling” in the protein. p.Arg85Trp (or R85W)
cDNA Notation The precise coordinate on the DNA strand. c.253C>T
Zygosity Confirms how many copies are affected. Heterozygous (one copy)
Classification The lab’s confidence that the variant causes disease. Pathogenic or Likely Pathogenic

A Note on VUS: If your report says Variant of Uncertain Significance (VUS), it means the lab does not have enough evidence to prove the variant causes disease. A VUS should not be used alone to confirm a diagnosis, predict future disease, or make treatment decisions. Consult a genetic counselor to guide family testing.

Nomenclature: Because of how genes are spliced (assembled), the same variant might be numbered differently in older reports (for example, p.Arg127Trp instead of p.Arg85Trp) [10][11]. If the numbers on your report don’t match exactly, ask your geneticist.

Common questions in this guide

What HNF4A variant is most often associated with FRTS4?
The HNF4A p.Arg85Trp variant, also written as R85W, is the variant most often reported in FRTS4. Other HNF4A variants have been reported, but not every HNF4A variant causes the same kidney-and-pancreas condition.
How can genetic testing help confirm FRTS4?
A pathogenic or likely pathogenic HNF4A variant that fits the clinical findings can support a diagnosis of FRTS4 and distinguish it from other Fanconi syndromes. A variant of uncertain significance, or VUS, does not confirm the diagnosis by itself.
What information should I check on an FRTS4 genetic report?
Look for the gene name, the protein change, the DNA-level or cDNA notation, the zygosity, and the laboratory classification. For FRTS4, the report may identify HNF4A and a variant such as p.Arg85Trp or R85W.
What does a VUS mean on an HNF4A genetic test?
A VUS means the laboratory does not yet have enough evidence to determine whether the variant causes disease. It should not be used alone to confirm FRTS4, predict future disease, or make treatment decisions; a genetic counselor can help explain next steps.
Is FRTS4 inherited from a parent?
FRTS4 is autosomal dominant, so one disease-causing HNF4A copy is enough to cause the condition. If a parent carries the variant, each child has a 50% chance of inheriting it, although some cases result from a new, or de novo, variant.
Why might the same HNF4A variant have different numbers on genetic reports?
Variant numbering can differ when laboratories use different HNF4A transcripts or older naming systems. If a report uses a label that does not match p.Arg85Trp or R85W, ask a geneticist to compare the transcript and DNA-level notation.

Get notified when new evidence is published on Fanconi renotubular syndrome 4 with maturity-onset diabetes of the young.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (11)
  1. 1

    Phenotypic Spectrum of HNF4α-Associated Fanconi Renotubular Syndrome.

    Emma F, Böckenhauer D, Mallett AJ, et al.

    Kidney international reports 2026; (11(8)):106616 doi:10.1016/j.ekir.2026.106616.

    PMID: 42440446
  2. 2

    Functional characterization of HNF4A gene variants identify promoter and cell line specific transactivation effects.

    Kaci A, Solheim MH, Silgjerd T, et al.

    Human molecular genetics 2024; (33(10)):894-904 doi:10.1093/hmg/ddae027.

    PMID: 38433330
  3. 3

    A Case of Hyperinsulinemic Hypoglycaemia Associated with Atypical Fanconi Renal Tubulopathy Syndrome Caused by an HNF4A Variant.

    Garriga-Edo S, Peris-Serra L, Ríos Duro H, et al.

    Case reports in nephrology and dialysis 2026; (16(1)):10-19 doi:10.1159/000549545.

    PMID: 41488815
  4. 4

    Band-shaped keratopathy in HNF4A-related Fanconi syndrome: a case report and review of the literature.

    Verma A, Mishra DK, Edward DP, Ramappa M

    Ophthalmic genetics 2024; (45(3)):246-251 doi:10.1080/13816810.2023.2285310.

    PMID: 37997707
  5. 5

    Heterozygous recurrent HNF4A variant p.Arg85Trp causes Fanconi renotubular syndrome 4 with maturity onset diabetes of the young, an autosomal dominant phenocopy of Fanconi Bickel syndrome with colobomas.

    Sheppard SE, Barrett B, Muraresku C, et al.

    American journal of medical genetics. Part A 2021; (185(2)):566-570 doi:10.1002/ajmg.a.61978.

    PMID: 33251707
  6. 6

    Nephrolithiasis, kidney failure and bone disorders in Dent disease patients with and without CLCN5 mutations.

    Anglani F, D'Angelo A, Bertizzolo LM, et al.

    SpringerPlus 2015; (4()):492 doi:10.1186/s40064-015-1294-y.

    PMID: 26389017
  7. 7

    A young man with recurrent kidney stones and renal failure.

    Gill J, Wiederkehr MR

    Clinical nephrology. Case studies 2020; (8()):85-90 doi:10.5414/CNCS110198.

    PMID: 33163328
  8. 8

    Two new missense mutations in the protein interaction ASH domain of OCRL1 identified in patients with Lowe syndrome.

    Perdomo-Ramirez A, Antón-Gamero M, Rizzo DS, et al.

    Intractable & rare diseases research 2020; (9(4)):222-228 doi:10.5582/irdr.2020.03092.

    PMID: 33139981
  9. 9

    Diazoxide and Continuous Glucose Monitoring as Treatment in a Neonate with Hyperinsulinemic Hypoglycemia due to HNF4A Mutation

    Sotiriou G, Xinias S, Diamantidou V, et al.

    Journal of clinical research in pediatric endocrinology 2025; doi:10.4274/jcrpe.galenos.2025.2025-4-12.

    PMID: 40960027
  10. 10

    Novel Fanconi renotubular syndromes provide insights in proximal tubule pathophysiology.

    Lemaire M

    American journal of physiology. Renal physiology 2021; (320(2)):F145-F160 doi:10.1152/ajprenal.00214.2020.

    PMID: 33283647
  11. 11

    The Common p.R114W HNF4A Mutation Causes a Distinct Clinical Subtype of Monogenic Diabetes.

    Laver TW, Colclough K, Shepherd M, et al.

    Diabetes 2016; (65(10)):3212-7 doi:10.2337/db16-0628.

    PMID: 27486234

This page explains FRTS4 genetic testing and report terms for informational purposes only and does not constitute medical advice. A medical geneticist or genetic counselor should interpret your result and advise on diagnosis, care, and family testing.